On May 9, 2022, Blue Ocean Structure Investment Company Limited announced that it has filed a notice of petition against Global Cord Blood Corporation seeking an order to 1) refrain the Company from acquiring Cellenkos Inc; 2) amend and restate its memorandum and articles of association to eliminate the classification of the board and to add shareholder protective provisions; and 3) convene an extraordinary general meeting to propose the removal of the current Board and the appointment of alternative directors proposed by Blue Ocean Structure Investment Company Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | 0.00% | -7.41% | +2.46% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+2.46% | 167M | |
-14.58% | 84.68B | |
+15.05% | 81.12B | |
+10.49% | 29.59B | |
-10.17% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.86% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- CORBF Stock
- News Global Cord Blood Corporation
- Blue Ocean Structure Investment Company Limited Sues Global Cord Blood Corporation